Publications by authors named "Jan Dorr"

Claim this Profile
E
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers.
Giulia Montuori, Fengyu Tu, Di Qin, Rachel Schmargon, Elias Rodriguez-Fos

Cancer Discov· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroprotective role of high dose Vitamin D supplementation in multiple sclerosis: Sub-analysis of the EVIDIMS trial.
Enrique Gomez-Figueroa, Carlos Moreno-Bernardino, Priscilla Bäcker-Koduah, Jan Dörr, Kerstin Rubarth

Mult Scler Relat Disord· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogene Silencing via ecDNA Micronucleation.
Lotte Brückner, Robin Xu, Jun Tang, Alexander Herrmann, Ivy Tsz-Lo Wong

bioRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control.
Dimitri Belenki, Paulina Richter-Pechanska, Zhiting Shao, Animesh Bhattacharya, Andrea Lau

Nat Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinated inheritance of extrachromosomal DNAs in cancer cells.
King L Hung, Matthew G Jones, Ivy Tsz-Lo Wong, Ellis J Curtis, Joshua T Lange

Nature· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characterization and Ancillary Tests in Susac Syndrome: A Systematic Review.
Adi Wilf-Yarkoni, Ofir Zmira, Assaf Tolkovsky, Barak Pflantzer, Shany G Gofrit

Neurol Neuroimmunol Neuroinflamm· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Passenger Gene Coamplifications Create Collateral Therapeutic Vulnerabilities in Cancer.
Yi Bei, Luca Bramé, Marieluise Kirchner, Raphaela Fritsche-Guenther, Severine Kunz

Cancer Discov· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinated inheritance of extrachromosomal DNA species in human cancer cells.
King L Hung, Matthew G Jones, Ivy Tsz-Lo Wong, Joshua T Lange, Jens Luebeck

bioRxiv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susac Syndrome.
Markus Krämer, Jan Dörr, Marius Ringelstein, Bianca Krämer, Catharina C Groß

Dtsch Arztebl Int· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a Marker of N-Acetylglucosamine With Progressive Multiple Sclerosis and Neurodegeneration.
Alexander U Brandt, Michael Sy, Judith Bellmann-Strobl, Barbara L Newton, Judy Pawling

JAMA Neurol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells.
Svenja C Schwichtenberg, Anne Wisgalla, Maria Schroeder-Castagno, Cesar Alvarez-González, Stephan Schlickeiser

Neurotherapeutics· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Mutations Including the Rare Pathogenic Variant c.3206delC in the Gene Cause Ataxia Teleangiectasia-Associated Primary Central Nervous System Lymphoma.
Jan R Dörr, Anne Thorwarth, Agnieszka Mizia-Malarz, Josefine Radke, Anna Tietze

Children (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial.
Rebekka Rust, Claudia Chien, Michael Scheel, Alexander U Brandt, Jan Dörr

Neurol Neuroimmunol Neuroinflamm· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial.
Judith Bellmann-Strobl, Friedemann Paul, Jens Wuerfel, Jan Dörr, Carmen Infante-Duarte

Neurol Neuroimmunol Neuroinflamm· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal Thickness Analysis in Progressive Multiple Sclerosis Patients Treated With Epigallocatechin Gallate: Optical Coherence Tomography Results From the SUPREMES Study.
Katharina Klumbies, Rebekka Rust, Jan Dörr, Frank Konietschke, Friedemann Paul

Front Neurol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of vitamin D supplementation on N-glycan branching and cellular immunophenotypes in MS.
Priscilla Bäcker-Koduah, Carmen Infante-Duarte, Federico Ivaldi, Antonio Uccelli, Judith Bellmann-Strobl

Ann Clin Transl Neurol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients.
Kolja Schleich, Julia Kase, Jan R Dörr, Saskia Trescher, Animesh Bhattacharya

Nat Commun· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial.
Christian Albert, Janine Mikolajczak, Anja Liekfeld, Sophie K Piper, Michael Scheel

BMC Neurol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D and Disease Severity in Multiple Sclerosis-Baseline Data From the Randomized Controlled Trial (EVIDIMS).
Priscilla Bäcker-Koduah, Judith Bellmann-Strobl, Michael Scheel, Jens Wuerfel, Klaus-Dieter Wernecke

Front Neurol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose vitamin D supplementation in multiple sclerosis - results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial.
Jan Dörr, Priscilla Bäcker-Koduah, Klaus-Dieter Wernecke, Elke Becker, Frank Hoffmann

Mult Scler J Exp Transl Clin· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8 T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome.
Catharina C Gross, Céline Meyer, Urvashi Bhatia, Lidia Yshii, Ilka Kleffner

Nat Commun· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Modification in Multiple Sclerosis by Flupirtine-Results of a Randomized Placebo Controlled Phase II Trial.
Jan Dörr, Klaus-Dieter Wernecke, Jens Würfel, Judith Bellmann-Strobl, Volker Siffrin

Front Neurol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal visual resolution and disease severity in MS.
Noah Ayadi, Jan Dörr, Seyedamirhosein Motamedi, Kay Gawlik, Judith Bellmann-Strobl

Neurol Neuroimmunol Neuroinflamm· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Senescence-associated reprogramming promotes cancer stemness.
Maja Milanovic, Dorothy N Y Fan, Dimitri Belenki, J Henry M Däbritz, Zhen Zhao

Nature· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue.
Gunnar Gaede, Marina Tiede, Ina Lorenz, Alexander U Brandt, Caspar Pfueller

Neurol Neuroimmunol Neuroinflamm· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis